Form 8-K - Current report:
SEC Accession No. 0001144204-19-046623
Filing Date
2019-10-01
Accepted
2019-10-01 08:00:21
Documents
5
Period of Report
2019-10-01
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv530209_8k.htm 8-K 21238
2 EXHIBIT 99.1 tv530209_ex99-1.htm EX-99.1 5797
3 EXHIBIT 99.2 tv530209_ex99-2.htm EX-99.2 9870
4 GRAPHIC logo_001.jpg GRAPHIC 4031
5 GRAPHIC logo_002.jpg GRAPHIC 4031
  Complete submission text file 0001144204-19-046623.txt   49470
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 191127577
SIC: 2834 Pharmaceutical Preparations